- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06507137
Fractal-based Gait Training in Older Adults
September 16, 2025 updated by: Egas Moniz - Cooperativa de Ensino Superior, CRL
Fractal-based Gait Training in Older Adults: Implications to Motor Control and Neuroplasticity
The purpose of the study is to investigate the influence of walking with external visual cues on brain adaptations.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Monte de Caparica
-
Almada, Monte de Caparica, Portugal, 2829-699
- Egas Moniz School of Health and Science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Exclusion Criteria:
- Neurologic conditions;
- Lower limb disabilities or disease;
- Not able to provide informed consent;
- Unable to walk unassisted for 10-minutes continuously;
- Score below 24 in the Mini-Mental State Examination (MMSE);
- Have a history of falls in the prior six months;
- Have an implanted device (e.g., pacemakers);
- Medication advised against the application of Transcranial Magnetic Stimulation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control
|
Walking in a treadmill
|
|
Experimental: Fractal
|
Walking in a treadmill while synchronizing their steps with fractal external visual cues
|
|
Experimental: Isochronous
|
Walking in a treadmill while synchronizing their steps with isochronous external visual cues
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fractal scaling exponent (α) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups.
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
The fractal scaling exponent quantifies the complexity of a physiological signal and detects the presence of statistical persistence in a given time series.
This parameter is calculated using Detrended Fluctuation Analysis (DFA) from each time series (stride time and stride length).
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Corticospinal excitability (CSE) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups.
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
CSE is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS).
This parameter provides information regarding the level of excitability of the corticospinal tract.
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Short-Interval Intracortical Inhibition (SICI) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups.
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
SICI is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS).
This parameter provides information regarding the level of inhibition of the motor cortex.
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Intracortical Facilitation (ICF) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups.
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
ICF is a parameter extracted through the application of Transcranial Magnetic Stimulation (TMS).
This parameter provides information regarding the level of facilitation of the motor cortex.
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Ankle, Knee and Hip joints range of motion's changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
Joint range of motion is measured through a motion capture system and quantifies the excursion of the joint during the gait task in degrees (º).
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Ankle, Knee and Hip joints maximum value changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
Joint maximum value is measured through a motion capture system and quantifies the maximum joint flexion during the gait task in degrees (º).
This measure will be used to calculate joint range of motion (outcome 2).
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Ankle, Knee and Hip joints minimum value changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
Joint minimum value is measured through a motion capture system and quantifies the minimum joint flexion during the gait task in degrees (º).
This measure will be used to calculate joint range of motion (outcome 2).
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Ankle, Knee and Hip joints angles during initial contact changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
Joint angle during initial contact is measured through a motion capture system and quantifies the angle of the respective joint at the moment the heel touches the ground during a gait cycle (heel strike) in degrees (º).
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Ankle, Knee and Hip joints angles during peak ground reaction force changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups during a gait cycle
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
|
Coefficient of variation (CV) changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups.
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
CV is a common linear measure that translates the amount of variability within the signal and is calculated through the standard deviation normalised to the mean from each time series (stride time and stride length).
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
|
Electromyography co-contraction changes from baseline (PRE to POS, PRE to FUP, POS to FUP) both within and between Fractal, Isochronous and Control groups.
Time Frame: PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
Co-contraction is the simultaneous activation of the agonist and antagonist muscles during a task.
This parameter It is an important mechanism of the central nervous system to regulate joint stability and provide movement accuracy.
|
PRE (baseline), POS (4 weeks after), FUP (8 weeks after)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 25, 2024
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
June 19, 2024
First Submitted That Met QC Criteria
July 11, 2024
First Posted (Actual)
July 18, 2024
Study Record Updates
Last Update Posted (Actual)
September 22, 2025
Last Update Submitted That Met QC Criteria
September 16, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FRACTRAIN-1378/24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
Synbiotic HealthMusB ResearchRecruitingHealthy Aging | Anti AgingUnited States
-
Research Centre for Natural SciencesSemmelweis University; HUN-REN Institute of Experimental MedicineActive, not recruitingHealthy Aging | Neurocognitive AgingHungary
Clinical Trials on Fractal
-
Necmettin Erbakan UniversityCompleted
-
Recep Tayyip Erdogan University Training and Research...CompletedDental Caries in Children | Radiology | Pediatric PatientsTurkey
-
London Metropolitan UniversityCompleted
-
Egas Moniz - Cooperativa de Ensino Superior, CRLRecruitingAnterior Cruciate Ligament Reconstruction | Athlete | Anterior Cruciate Ligament Reconstruction RehabilitationPortugal
-
Egas Moniz - Cooperativa de Ensino Superior, CRLFundação para a Ciência e a Tecnologia; University of EssexCompleted
-
Egas Moniz - Cooperativa de Ensino Superior, CRLFundação para a Ciência e a TecnologiaRecruiting
-
University of NebraskaTerminatedGait Disorders, NeurologicUnited States
-
Jagiellonian UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted